Katherine A. High
Katherine A. High | |
|---|---|
| Born | |
| Nationality | American |
| Alma mater | Harvard College, University of North Carolina School of Medicine |
| Known for | Gene Therapy |
| Scientific career | |
| Fields | Hematology |
| Institutions | University of Pennsylvania, Spark Therapeutics |
| Academic advisors | Edward J. Benz, Jr. |
Katherine A. High is an American doctor who is a Emeritus Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania. She is a co-founder, president and chief scientific officer of Spark Therapeutics.[1] High earned a A.B. in chemistry at the Harvard College in 1972 and a M.D in 1978 at University of North Carolina School of Medicine. She did her training in hematology with Edward J. Benz, Jr. at Yale University.[2]
Her work is focused on the use of gene therapy for hemophilia. She was the director of the Center for Cellular and Molecular Therapeutics, and as of 2001[update] head of hematology research,[1] at the Children's Hospital of Philadelphia and an investigator of the Howard Hughes Medical Institute.[3][4] High is a member of the Institute of Medicine and a fellow of the American Academy of Arts and Sciences.
References
- ^ a b Yarbrough, Cathy (3 September 2018). "Gene Therapy Pioneer's 30 Years Of Problem-Solving". Life Science Leader.
- ^ Wilson, James M. (1 December 2016). "Interview with Katherine A. High, MD". Human Gene Therapy Clinical Development. 27 (4): 127–131. doi:10.1089/humc.2016.29021.int. ISSN 2324-8637. Retrieved 1 October 2017.
- ^ "Katherine High" (PDF). Retrieved 1 October 2017.
- ^ "Katherine A. High, MD - IHG Symposium 2015". IHG Symposium 2015. 1 September 2015. Retrieved 1 October 2017.
External links
| Authority control databases: Academics |
|---|
